Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
3 other identifiers
observational
2,632
1 country
2
Brief Summary
The purpose of this study is to determine if the metabolic syndrome is a risk factor for cognitive decline and if this association is modified by inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1997
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1997
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2002
CompletedFirst Submitted
Initial submission to the registry
December 16, 2004
CompletedFirst Posted
Study publicly available on registry
December 17, 2004
CompletedNovember 1, 2005
December 1, 2004
December 16, 2004
October 31, 2005
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Aged 70 to 79
- White or Black
- Community-dwelling in Memphis, TN or Pittsburgh, PA vicinity
- Well-functioning (no difficulty in walking a quarter of a mile or going up 10 steps without resting)
You may not qualify if:
- Any difficulty with activities of daily living
- Clinical dementia
- Inability to communicate with interviewer
- Intention of moving out of vicinity in the next year
- Active treatment for cancer in the previous 3 years
- Participation in a trial involving a lifestyle intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Aging (NIA)lead
- Paul Beeson Faculty Scholars Programcollaborator
- University of California, San Franciscocollaborator
Study Sites (2)
Unknown Facility
Pittsburgh, Pennsylvania, United States
Unknown Facility
Memphis, Tennessee, United States
Related Publications (3)
Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003 Jul 8;61(1):76-80. doi: 10.1212/01.wnl.0000073620.42047.d7.
PMID: 12847160BACKGROUNDKalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2255-60. doi: 10.1161/01.atv.20.10.2255.
PMID: 11031212BACKGROUNDYaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004 Nov 10;292(18):2237-42. doi: 10.1001/jama.292.18.2237.
PMID: 15536110RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristine Yaffe, MD
University of California, San Francisco
Study Design
- Study Type
- observational
- Observational Model
- NATURAL HISTORY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
December 16, 2004
First Posted
December 17, 2004
Study Start
January 1, 1997
Study Completion
December 1, 2002
Last Updated
November 1, 2005
Record last verified: 2004-12